Clinical Trial Update: CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial testing corticosteroids for inflammation-enriched cardiogenic shock in patients with heart failure; the study is currently not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cardiogenic Shock, Heart Failure | Phase 2 | Status: NOT_YET_RECRUITING